Join KBI Biopharma, Inc. at DCAT 2023! Be sure to schedule a meeting with our executive team, including Abdel Toumi (Chief Business Officer), Aruna Mor (SVP Global Marketing & Business Development [Americas]), Roland Hecht (SVP Business Development [EMEA & APAC]), and Mike Cavanaugh (VP, Business Development). We look forward to seeing you in New York!
KBI Biopharma is a leading global contract development and manufacturing organization (CDMO) providing fully integrated, accelerated drug development and biologics manufacturing services and expertise to life science companies. With each of our 500+ client partners, we work closely to personalize and accelerate drug development programs. Built upon a foundation of world-class analytics capabilities and extensive scientific and technical expertise, we deliver robust process development and clinical and commercial cGMP manufacturing services for mammalian, microbial, and cell therapy programs. Recognized for quality manufacturing, we help clients advance drug candidates into the clinic and beyond.
DCAT Week is the premier event held annually in New York City for companies engaged in the Global Bio/Pharmaceutical Manufacturing Value Chain.